Skip to content

Commit

Permalink
Browse files Browse the repository at this point in the history
Update 57-medical-university-of-graz-mug-graz-austria.html
As requested by "Dr. Heimo Müller" <heimo.mueller@medunigraz.at>.
  • Loading branch information
donald committed Aug 23, 2017
1 parent 3bc2cae commit 9cdf1c4
Showing 1 changed file with 87 additions and 11 deletions.
Expand Up @@ -208,22 +208,98 @@ <h3><a href="http://www.meduni-graz.at/en/" target="_blank"><img style="border-w
<p>The Medical University of Graz (MUG) is associated with the University Clinics of Graz, with 1600 beds and 78000 patients/ year. This facilitates close integration of research and routine clinical services. An important asset of the MUG established in an integrated setting of clinical routine and latest medical research is its ISO- certified biobank core-facility, hosting 3.1 million formalin-fixed paraffin-embedded (FFPE) and more than 120,000 cryopreserved tissue samples and 350,000 serum samples from in total 1.2 mio patients, which according to the BBMRI questionnaire is the largest collection in Europe. The resources are complemented by latest morphological technologies (Laser capture microdissection, LSM, electron microscopy), SPF facility for animal experiments (tumor xenografts and transgenic models) and ISO-certified RNA and DNA analysis (real-time PCR, DNA microarrays, 454-sequencing) as well as proteomics and metabolomics (lipidomics) platforms. All these research resources of the Medical University of Graz are centralized in the Organisational Unit for<br />Research Infrastructure and operated by first class permanent core facility staff comprising of experienced scientists and skilled technicians.</p>
<p>&nbsp;</p>
<h3>Profile of staff members</h3>
<p>Kurt Zatloukal is Professor of Pathology at the Medical University of Graz with specialisation in molecular pathology, focusing on metabolic and neoplastic diseases, mainly of the liver. He was a member of the Bioethics Commission at the Austrian Federal Chancellery and is the Austrian representative in the OECD task force on biological resource centres and the Roadmap Working Group of the European Strategy Forum on Research Infrastructure. Currently he coordinates the preparatory phase of BBMRI and leads the work on pre-analytical standards for tissue banking in the FP7 large integrated project SPIDIA. Additionally, he acts as member of the executive steering committee of the <a href="http://www.p3g.org/" target="_blank">P3G</a> consortium and chairs the governance council of the <a href="http://www.p3g.org/bioshare/" target="_blank">BioShare</a> project. In context of the <a href="http://www.gen-au.at/index.jsp?lang=en" target="_blank">Austrian Genome Programme (GEN-AU)</a>, he coordinates a Biobank project which is based on a comprehensive collection of diseased and healthy tissues representing a non- selected central European population. Heimo Müller studied mathematics in Graz and Vienna. He started his scientific career in the field of computer graphics and multimedia at Joanneum, worked as Marie Curie fellow at the Faculty of Arts of the Vrije Universiteit Amsterdam and was the founding head of the Information-Design programme at the FH Joanneum in Graz. Within the preparatory phase of BBMRI Heimo Müller presently investigates large inhomogeneous clinical data collections.</p>
<p>Kurt Zatloukal is Professor of Pathology at the Medical University of
Graz with specialisation in molecular pathology, focusing on metabolic
and neoplastic diseases, mainly of the liver. He was a member of the
Bioethics Commission at the Austrian Federal Chancellery and is the
Austrian representative in the OECD task force on biological resource
centres and the Roadmap Working Group of the European Strategy Forum on
Research Infrastructure. Currently he coordinates the preparatory phase
of BBMRI and leads the work on pre-analytical standards for tissue
banking in the FP7 large integrated project SPIDIA. Additionally, he
acts as member of the executive steering committee of the <a href="http://www.p3g.org/">P3G</a>
consortium and chairs the governance council of
the <a href="http://www.p3g.org/bioshare/">BioShare</a> project. In context of the
<a href="http://www.gen-au.at/index.jsp?lang=en">Austrian Genome Programme (GEN-AU)</a>,
he coordinates a Biobank
project which is based on a comprehensive collection of diseased and
healthy tissues representing a non- selected central European
population. Andreas Holzinger is Professor at the Institute for Medical
Informatics/Statistics at the Medical University Graz, and Associate
Professor at the Faculty of Computer Science at Graz University of
Technology. He serves as consultant for the Canadian, US, UK, Swiss,
French, Italian and Dutch governments, for the German Excellence
Initiative, and as national expert in the European Commission. Andreas
obtained a PhD in Cognitive Science from Graz University in 1998 and his
Habilitation (second PhD) in Computer Science from Graz University of
Technology in 2003. Andreas was Visiting Professor in Berlin, Innsbruck,
London (twice) and Aachen. Andreas and his Group work on a synergistic
combination of methodologies of two areas that offer ideal conditions
towards understanding intelligence: Human-Computer Interaction
(HCI) and Knowledge Discovery/Data Mining (KDD), with the central goal
of supporting human intelligence with machine learning. In 2011 Andreas
founded the international Expert Network HCI-KDD and organises regularly
workshops and conferences. Heimo Müller studied mathematics in Graz
and Vienna. He started his scientific career in the field of computer
graphics and multimedia at Joanneum, worked as Marie Curie fellow at the
Faculty of Arts of the Vrije Universiteit Amsterdam and was the founding
head of the Information-Design programme at the FH Joanneum in Graz.
Within the preparatory phase of BBMRI Heimo Müller presently
investigates large inhomogeneous clinical data collections.
</p>
<p>&nbsp;</p>
<h3>Webpage</h3>
<p><a href="http://www.meduni-graz.at/en/" target="_blank">Medical University of Graz</a></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h3>Recent publications relevant to the project</h3>
<p>Min L, Ji Y, Bakiri L, Qiu Z, Cen J, Chen X, Chen L, Scheuch H, Zheng H, QinL, Zatloukal K, Hui L, Wagner EF. Liver cancer initiation is controlled by AP-1through SIRT6-dependent inhibition of survivin. Nat Cell Biol. 2012 Oct 7. doi:10.1038/ncb2590.</p>
<p>&nbsp;</p>
<p>Jozefczuk J, Kashofer K, Ummanni R, Henjes F, Rehman S, Geenen S, Wruck W,Regenbrecht C, Daskalaki A, Wierling C, Turano P, Bertini I, Korf U, Zatloukal K,Westerhoff HV, Lehrach H, Adjaye J. A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells.Front Physiol. 2012;3:339.</p>
<p>&nbsp;</p>
<p>Eder J, Gottweis H, Zatloukal K. IT solutions for privacy protection inbiobanking. Public Health Genomics. 2012;15(5):254-62.</p>
<p>&nbsp;</p>
<p>Wichmann HE, Kuhn KA, Waldenberger M, Schmelcher D, Schuffenhauer S, MeitingerT, Wurst SH, Lamla G, Fortier I, Burton PR, Peltonen L, Perola M, Metspalu A,Riegman P, Landegren U, Taussig MJ, Litton JE, Fransson MN, Eder J,Cambon-Thomsen A, Bovenberg J, Dagher G, van Ommen GJ, Griffith M, Yuille M,Zatloukal K. Comprehensive catalog of European biobanks. Nat Biotechnol. 2011 Sep 8;29(9):795-7.</p>
<p>&nbsp;</p>
<p>Yuille M, van Ommen GJ, Bréchot C, Cambon-Thomsen A, Dagher G, Landegren U, Litton JE, Pasterk M, Peltonen L, Taussig M, Wichmann HE, Zatloukal K. Biobanking for Europe. Brief Bioinform. 2008 Jan;9(1):14-24.</p>
Min L, Ji Y, Bakiri L, Qiu Z, Cen J, Chen X, Chen L, Scheuch H, Zheng H,
QinL, Zatloukal K, Hui L, Wagner EF. Liver cancer initiation is
controlled by AP-1through SIRT6-dependent inhibition of survivin. Nat
Cell Biol. 2012 Oct 7. doi:10.1038/ncb2590.
<p>&nbsp;</p>
Jozefczuk J, Kashofer K, Ummanni R, Henjes F, Rehman S, Geenen S, Wruck
W,Regenbrecht C, Daskalaki A, Wierling C, Turano P, Bertini I, Korf U,
Zatloukal K,Westerhoff HV, Lehrach H, Adjaye J. A Systems Biology
Approach to Deciphering the Etiology of Steatosis Employing
Patient-Derived Dermal Fibroblasts and iPS Cells.Front Physiol.
2012;3:339.
<p>&nbsp;</p>

Eder J, Gottweis H, Zatloukal K. IT solutions for privacy protection
inbiobanking. Public Health Genomics. 2012;15(5):254-62.
<p>&nbsp;</p>

Holzinger, A., Stocker, C., Bruschi, M., Auinger, A., Silva, H., Gamboa,
H. &amp; Fred, A. 2012. On Applying Approximate Entropy to ECG Signals for
Knowledge Discovery on the Example of Big Sensor Data. In: Huang, R.,
Ghorbani, A., Pasi, G., Yamaguchi, T., Yen, N. &amp; Jin, B. (eds.) Active
Media Technology, Lecture Notes in Computer Science, LNCS 7669. Berlin
Heidelberg: Springer, pp. 646-657, doi:10.1007/978-3-642-35236-2_64.
<p>&nbsp;</p>

Holzinger, A., Kickmeier-Rust, M. D., Wassertheurer, S. &amp; Hessinger, M.
2009. Learning performance with interactive simulations in medical
education: Lessons learned from results of learning complex
physiological models with the HAEMOdynamics SIMulator. Computers &amp;
Education, 52, (2), 292-301, doi:10.1016/j.compedu.2008.08.008.=20
<p>&nbsp;</p>

Wichmann HE, Kuhn KA, Waldenberger M, Schmelcher D, Schuffenhauer S,
MeitingerT, Wurst SH, Lamla G, Fortier I, Burton PR, Peltonen L, Perola
M, Metspalu A,Riegman P, Landegren U, Taussig MJ, Litton JE, Fransson
MN, Eder J,Cambon-Thomsen A, Bovenberg J, Dagher G, van Ommen GJ,
Griffith M, Yuille M,Zatloukal K. Comprehensive catalog of European
biobanks. Nat Biotechnol. 2011 Sep 8;29(9):795-7.
<p>&nbsp;</p>

Yuille M, van Ommen GJ, Bréchot C, Cambon-Thomsen A, Dagher G,
Landegren U, Litton JE, Pasterk M, Peltonen L, Taussig M, Wichmann HE,
Zatloukal K. Biobanking for Europe. Brief Bioinform. 2008
Jan;9(1):14-24.
<p>&nbsp;</p>


</div>
</div>

Expand Down Expand Up @@ -268,4 +344,4 @@ <h3>Recent publications relevant to the project</h3>

</body>

</html>
</html>

0 comments on commit 9cdf1c4

Please sign in to comment.